{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:16:20Z","timestamp":1794564980586,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/md.0000000000005532","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T17:34:43Z","timestamp":1484069683000},"page":"e5532","source":"Crossref","is-referenced-by-count":39,"title":["Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion"],"prefix":"10.1097","volume":"96","author":[{"given":"Hua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210226","first-page":"1987","article-title":"Am J Respir Crit Care M","volume":"162","year":"2000","journal-title":"ed"},{"key":"R2-14-20210226","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"5","author":"Clive","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-14-20210226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0033-8389(05)70168-8","article-title":"Management of malignant pleural effusions and pneumothorax","volume":"38","author":"Erasmus","year":"2000","journal-title":"Radiol Clin North Am"},{"key":"R4-14-20210226","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R5-14-20210226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0003-4975(94)00614-D","article-title":"Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion","volume":"59","author":"Matsuzaki","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R6-14-20210226","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.athoracsur.2004.05.025","article-title":"Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis","volume":"78","author":"Matsuzaki","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"R7-14-20210226","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00432-013-1526-x","article-title":"Intrapleural hyperthermic perfusion using distilled water at 48 degrees C for malignant pleural effusion","volume":"139","author":"Ba","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"R8-14-20210226","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.rmed.2013.01.010","article-title":"Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies","volume":"107","author":"Isik","year":"2013","journal-title":"Respir Med"},{"key":"R9-14-20210226","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.18632\/oncotarget.6491","article-title":"EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"R10-14-20210226","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1569-9293(03)00197-X","article-title":"Combined surgery of intrapleural perfusion hyperthermic chemotherapy and panpleuropneumonectomy for lung cancer with advanced pleural spread: a pilot study","volume":"2","author":"Shigemura","year":"2003","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R11-14-20210226","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11748-015-0535-x","article-title":"Interim results of pleurectomy\/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy","volume":"63","author":"Ishibashi","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R12-14-20210226","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/OTT.S41347","article-title":"Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination","volume":"6","author":"Yu","year":"2013","journal-title":"Onco Targets Ther"},{"key":"R13-14-20210226","doi-asserted-by":"crossref","first-page":"21570","DOI":"10.18632\/oncotarget.7622","article-title":"Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"R14-14-20210226","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00280-011-1765-y","article-title":"Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis","volume":"69","author":"Lombardi","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"R15-14-20210226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/fon.14.256","article-title":"Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience","volume":"11","author":"Migliore","year":"2015","journal-title":"Future Oncol"},{"key":"R16-14-20210226","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ejcts\/ezu217","article-title":"Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure","volume":"47","author":"Ried","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"R17-14-20210226","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ejcts\/ezv039","article-title":"Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapydagger","volume":"49","author":"Ambrogi","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"R18-14-20210226","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/ejso.2002.1323","article-title":"Intraoperative hyperthermic intrathoracic perfusion chemotherapy for pleural metastases of thymic neoplasms","volume":"28","author":"de Bree","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"R19-14-20210226","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1245\/ASO.2003.03.022","article-title":"Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma","volume":"10","author":"van Ruth","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R20-14-20210226","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1245\/s10434-007-9508-3","article-title":"Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin","volume":"14","author":"de Bree","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R21-14-20210226","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1245\/s10434-008-9899-9","article-title":"Surgical treatment in the management of malignant pleural mesothelioma: a single institution's experience","volume":"15","author":"van Sandick","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R22-14-20210226","doi-asserted-by":"crossref","first-page":"623417","DOI":"10.1155\/2012\/623417","article-title":"Hyperthermic intraoperative thoracoabdominal chemotherapy","volume":"2012","author":"Sugarbaker","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"R23-14-20210226","doi-asserted-by":"crossref","first-page":"471205","DOI":"10.1155\/2012\/471205","article-title":"Pharmacokinetics of hyperthermic intrathoracic chemotherapy following pleurectomy and decortication","volume":"2012","author":"Sugarbaker","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"R24-14-20210226","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jtcvs.2012.10.042","article-title":"Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation","volume":"145","author":"Cameron","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R25-14-20210226","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ejcts\/ezs418","article-title":"Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience","volume":"43","author":"Ried","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"R26-14-20210226","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jso.23321","article-title":"Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies","volume":"107","author":"Ried","year":"2013","journal-title":"J Surg Oncol"},{"key":"R27-14-20210226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1749-8090-9-125","article-title":"Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion","volume":"9","author":"Kerscher","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"R28-14-20210226","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/1097-0142(20011015)92:8<2197::AID-CNCR1563>3.0.CO;2-F","article-title":"Hyperthermic pleural perfusion with cisplatin: early clinical experience","volume":"92","author":"Yellin","year":"2001","journal-title":"Cancer"},{"key":"R29-14-20210226","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0003-4975(01)02786-2","article-title":"Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread","volume":"72","author":"Refaely","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R30-14-20210226","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jso.21230","article-title":"Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei","volume":"99","author":"Chua","year":"2009","journal-title":"J Surg Oncol"},{"key":"R31-14-20210226","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13019-015-0340-8","article-title":"Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion","volume":"10","author":"Moon","year":"2015","journal-title":"J Cardiothorac Surg"},{"key":"R32-14-20210226","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002800050721","article-title":"Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model","volume":"41","author":"Jacquet","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"R33-14-20210226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0001-4001(00)80009-4","article-title":"The effect of intra-abdominal temperature on the tissue and tumor diffusion of intraperitoneal cisplatin in a model of peritoneal carcinomatosis in rats","volume":"124","author":"Benoit","year":"1999","journal-title":"Chirurgie"},{"key":"R34-14-20210226","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#","article-title":"Selective heat sensitivity of cancer cells. Biochemical and clinical studies","volume":"20","author":"Cavaliere","year":"1967","journal-title":"Cancer"},{"key":"R35-14-20210226","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S","article-title":"Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis","volume":"39","author":"Overgaard","year":"1977","journal-title":"Cancer"},{"key":"R36-14-20210226","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1055-3207(03)00029-2","article-title":"Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents","volume":"12","author":"Sticca","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"R37-14-20210226","first-page":"605","article-title":"Differential response of normal and tumor microcirculation to hyperthermia","volume":"44","author":"Dudar","year":"1984","journal-title":"Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:38:52Z","timestamp":1620959932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201701060-00014"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005532","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}